Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware District of Columbia Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin Wyoming

About Michael Silber

This author has not yet filled in any details.
So far Michael Silber has created 2781 blog entries.

South Carolina

Reminder: federal law requires all providers who order, refer or prescribe services or items for Medicaid members to be enrolled in that state's Medicaid program. This requirement applies to pharmacist administering drugs as allowed under state protocols and submitting their NPIs in the prescriber field. Please review the Medicaid Enrollment of Ordering, Referring and Prescribing (ORP) Providers and Collection of ORP Data bulletin (MB# 25-015) published on July 2, 2025, as background.    

Also in South Carolina, NACDS met with the Department of Health and Human Services (SCDHHS) on March 11 and inquired about mass enrollment of pharmacists as Medicaid providers. The provider enrollment department has informed NACDS that, unfortunately, due to system limitations and CMS requirements, they are unable to offer a mass enrollment process to any provider type.  

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2026-04-03T09:31:18-04:00April 3, 2026|South Carolina|

Tennessee

The Department of Health (TDH) continues to closely monitor respiratory syncytial virus (RSV) activity across the state. Recent emergency department data indicates that RSV activity remains elevated but has begun decreasing in Tennessee. Due to continued RSV activity in the state, pediatric providers and hospitals may continue to administer RSV immunizations to eligible infants through April 30. RSV immunizations remain available for ordering through TennIIS for the Vaccines for Children (VFC) program.  

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2026-04-03T09:30:23-04:00April 3, 2026|Tennessee|

Virginia

Gov. Abigail Spanberger (D) signed SB 669 (Chapter 36)/HB 830, a key initiative of her administration to address PBM structure in the commercial market. The law will require all health insurance carriers to use a pass-through pricing model. It also will prohibit a PBM from reversing and/or resubmitting a pharmacy claim without meeting certain requirements; reducing any pharmacy payment through effective rates; and retroactively denying or reducing a claim or aggregate of claims, except under certain circumstances. Additionally, it requires the State Corporation Commission to compile a report of its examination of PBM steering practices with recommendations to the General Assembly by December 1, 2027. 

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2026-04-03T09:27:41-04:00April 3, 2026|Virginia|

Washington

The Board of Pharmacy has released updated self-inspection worksheets for 2025, covering various pharmacy practice settings and specialties. The comprehensive collection includes worksheets for general pharmacy operations, hospitals and HPACs, manufacturers, wholesalers and healthcare entities. Additional specialized addenda are available for long-term care facilities and various USP standards including nonsterile compounding (USP 795), sterile compounding (USP 797), hazardous drugs (USP 800) and radiopharmaceuticals (USP 825).

The Board also published a 2025 DSCSA self-inspection worksheet to help pharmacies comply with Drug Supply Chain Security Act (DSCSA) requirements. 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2026-04-03T09:27:01-04:00April 3, 2026|Washington|

West Virginia

Gov. Patrick Morrisey (R) signed HB 5430 , a bill that will further strengthen the state’s oversight of PBMs in both the commercial market and under the Public Employees Insurance Agency (PEIA). The law eliminates spread pricing; prohibits PBMs from using offshore group purchasing organizations (GPOs) to divert drug rebates; requires a 2026 pharmacy cost of dispensing study; and gives the Insurance Commissioner additional tools to regulate and oversee PEIA’s PBM.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2026-04-03T09:26:24-04:00April 3, 2026|West Virginia|

Alabama

The Department of Insurance (DOI) PBM Compliance Division has taken its first action against non-compliant PBMs. Actions have been filed against two entities: one taken in October against Drexi, Inc. for operating without a PBM license in the state, and one taken against Express Scripts, Inc. (ESI) this week for several violations, including charging of illegal fees; under payment of reimbursements; and failure and refusal to provide accounts, documents, records, files, information and matters relevant to the substance of complaints. The Department is enforcing Act 2025-36, also known as the Community Pharmacy Relief Act. Stay informed by visiting the DOI PBM Compliance Division page and the PBM Actions page.  

Also in Alabama, the Board of Pharmacy proposed these rules for adoption. The required public comment period is now open, and we encourage all members to review them.  

File written comments directly with the Board of Pharmacy as directed in the cover sheet for the rule. Deadlines for comments are provided on the rule filings. All written comments should be sent to Wpassmore@albop.com by the deadlines noted.  

Finally in Alabama, the Board of Pharmacy scheduled several upcoming meetings for 2026, including April 15, May 20, June 17, July 15, August 19, September 16, October 14, November 18 and December 16. All meetings begin at 9:00 am CST/CDT unless otherwise noted.  

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2026-03-27T09:40:16-04:00March 27, 2026|Alabama|

California

Due to an overwhelming response, the Board of Pharmacy is opening more spots for those interested in attending a listening session on pharmacists provided consultation. Seeking to minimize barriers that exist for pharmacists providing consultation to patients, the Board is interested in hearing from licensed California pharmacists to gather information to assist in evaluating the Board's current consultation requirements. In addition, separate listening sessions will be scheduled so the Board can obtain input from patients and public participants.  

Sessions will be conducted over WebEx. Please see the schedule of dates and times below. The Board respectfully requests individuals to register for ONLY ONE session to ensure other pharmacists have the same opportunity. If you previously registered for a session, please do not register for an additional session date.  

We have increased the meeting capacity; however, space is still limited, and registration is required. To register, click on the link below for your preferred session:  

Questions to be discussed during the listening session include:  

  1. Do you believe patient consultation is needed for all prescriptions? 
  2. How and where does the pharmacist provide patient consultation? 
  3. Does the patient receive the medication prior to consultation? 
  4. Should the pharmacy be required to document the consultation? 
  5. Can technology assist in identifying, documenting, and providing patient consultation? 
  6. What challenges or barriers exist making it difficult for the pharmacist to provide consultation? 
  7. What is your vision of best practice for patient consultation? 
  8. Are there opportunities for compensation for medication reviews and patient counseling? 
  9. If you mail or deliver prescriptions to patients, how do you provide consultation?Do you believe the requirements should be different than face-to-face consultation?  

The information provided will be considered during an upcoming Enforcement and Compounding Committee meeting.  

Also in California, the Board of Pharmacy published its 2026 Lawbook.   

Finally in California, NOTICE IS HEREBY GIVEN that the Board of Pharmacy (Board) has proposed modifications to the proposed regulatory text in section 1717.11 of article 2, division 17, title 16 of the California Code of Regulations, related to REMOTE PROCESSING. These regulations were originally noticed on January 9 and approved as modified by the Board at its March 18 meeting. Materials regarding this proposal can be found online or by requesting them from the contact person identified below.  

Any person who wishes to comment on the proposed modifications may do so by submitting written comments between March 19 and April 3 to the following:  

Contact Name: Debbie Damoth  

Address: 2720 Gateway Oaks Drive, Suite 100 Sacramento, CA 95833  

Fax number: (916) 574-8618  

Email Address: PharmacyRulemaking@dca.ca.gov  

Please note comments should be restricted to the most recent modifications made to the proposed regulations. The Board is not required to respond to comments on other aspects of the proposed regulations received in response to this notice.  

Any comments previously submitted remain in the rulemaking file and will be responded to by the Board's staff as part of the Final Statement of Reasons. All written comments received by April 3 that pertain to these modifications, will be reviewed and responded to by the Board's staff as part of the compilation of the rulemaking file.  

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2026-03-27T09:39:40-04:00March 27, 2026|California|

Colorado

SB26-032, a bill designed to expand access to pharmacy vaccine services by increasing pharmacists' authority to prescribe and administer vaccines and by providing liability protections for pharmacists, passed both legislative chambers and was sent to Gov. Jared Polis (D) to sign into law. 

Also in Colorado, after months of stakeholder negotiations, HB 26-1336, the Increase Access to Pharmacy Services bill that NACDS supports, was filed last week. The bill would strengthen coverage requirements for the clinical services pharmacists provide within their scope of practice and expand pharmacy technicians' technical and nondiscretionary tasks that do not require a pharmacist's expertise and professional judgement. The bill also includes provisions that expand pharmacists' scope of practice to provide test & treat services for families with children 12 years of age and younger. A hearing is scheduled in the House Health Care and Health Insurance Committee on March 31. 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2026-03-27T09:38:54-04:00March 27, 2026|Colorado|
Go to Top